Literature DB >> 24168983

Predictors of first recurrence of Clostridium difficile infections in children.

Sarah Tschudin-Sutter1, Pranita D Tamma, Aaron M Milstone, Trish M Perl.   

Abstract

Little is known regarding the risk of recurrence of Clostridium difficile infection (CDI) in children. In a 9-year cohort, 12% of hospitalized children with CDI had recurrent disease. Receipt of concomitant antibiotics and community-associated CDI were independently associated with recurrent disease in children hospitalized with CDI. Antibiotics administered for reasons other than treatment of CDI should be discontinued whenever possible.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24168983     DOI： 10.1097/INF.0000000000000108

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  9 in total

1.  Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients.

Authors:  Larry K Kociolek; Dale N Gerding; James R Osmolski; Sameer J Patel; David R Snydman; Laura A McDermott; David W Hecht
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

2.  Investigation of Clostridium difficile ribotypes in symptomatic patients of a German pediatric oncology center.

Authors:  Arne Simon; Markus Mock; Norbert Graf; Lutz von Müller
Journal:  Eur J Pediatr       Date:  2017-12-22       Impact factor: 3.183

Review 3.  Recent Issues in Pediatric Clostridium difficile Infection.

Authors:  Jason A Clayton; Philip Toltzis
Journal:  Curr Infect Dis Rep       Date:  2017-11-07       Impact factor: 3.725

4.  Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children.

Authors:  Maribeth R Nicholson; Paul D Mitchell; Erin Alexander; Sonia Ballal; Mark Bartlett; Penny Becker; Zev Davidovics; Michael Docktor; Michael Dole; Grace Felix; Jonathan Gisser; Suchitra K Hourigan; M Kyle Jensen; Jess L Kaplan; Judith Kelsen; Melissa Kennedy; Sahil Khanna; Elizabeth Knackstedt; McKenzie Leier; Jeffery Lewis; Ashley Lodarek; Sonia Michail; Maria Oliva-Hemker; Tiffany Patton; Karen Queliza; George H Russell; Namita Singh; Aliza Solomon; David L Suskind; Steven Werlin; Richard Kellermayer; Stacy A Kahn
Journal:  Clin Gastroenterol Hepatol       Date:  2019-04-19       Impact factor: 11.382

5.  Clostridium difficile infection in children: epidemiology and risk of recurrence in a low-prevalence country.

Authors:  A Lo Vecchio; L Lancella; C Tagliabue; C De Giacomo; S Garazzino; M Mainetti; L Cursi; E Borali; M V De Vita; E Boccuzzi; L Castellazzi; S Esposito; A Guarino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-30       Impact factor: 3.267

6.  Recurrent community-acquired Clostridium(Clostridioides)difficile infection in Serbianchildren.

Authors:  Stojanovic Predrag; Ed J Kuijper; Stojanović Nikola; Karuna E W Vendrik; Radulović Niko
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-12       Impact factor: 3.267

7.  Novel risk factors for recurrent Clostridium difficile infection in children.

Authors:  Maribeth R Nicholson; Isaac P Thomsen; James C Slaughter; C Buddy Creech; Kathryn M Edwards
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-01       Impact factor: 2.839

8.  Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study.

Authors:  Vanessa W Stevens; Cary Thurm; Elyse M Schwab; Matthew P Kronman; Jeffrey S Gerber; Samir S Shah; Jason G Newland; Joshua Courter; Sarah Parker; Thomas V Brogan; Adam L Hersh
Journal:  Infect Dis Ther       Date:  2016-03-14

9.  Dietary or supplemental fermentable fiber intake reduces the presence of Clostridium XI in mouse intestinal microbiota: The importance of higher fecal bacterial load and density.

Authors:  Wei Zheng; Kairui Wang; Yijun Sun; Shiu-Ming Kuo
Journal:  PLoS One       Date:  2018-10-02       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.